In this study, we used the CPTAC dataset to explore the molecular mechanisms of TOP2A protein in breast cancer, clear cell renal cell carcinoma, lung adenocarcinoma, ovarian cancer, and uterine corpus endometrial carcinoma in terms of total protein and phosphoprotein levels. This evidence concerns the gene TOP2A and clear cell renal carcinoma.